FSD Pharma Congratulates Partner Canntab on Launch of Research Partnership with Leading Orthopaedic Surgeon Dr. Don Garbuz, M.D.
FSD Pharma Receives First Delivery of Canntab Equipment with a Capacity to Manufacture Approx. 1,500,000 Tablets Per Day
Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment